Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (401-410 of 632) with videos related to

Pageof 64
Sort By:
Journal of Clinical Medicine|February 15, 2022
Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing CholangitisAnne-Christin Beatrice Wilde, Lena Maria Greverath, Lara Marleen Steinhagen, et al.
European Journal of Gastroenterology & Hepatology|October 2, 2009
Influence of alpha-1 antitrypsin heterozygosity on treatment efficacy of HCV combination therapyKarin F Kok, Hanneke van Soest, Antonius E van Herwaarden, et al.
Journal of Hepatology|November 1, 2011
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort studyJorg Petersen, Vlad Ratziu, Maria Buti, et al.
Gastroenterology|July 6, 2010
Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infectionThomas Berg, Patrick Marcellin, Fabien Zoulim, et al.
Hepatology (Baltimore, Md.)|July 4, 2009
Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patientsThomas Berg, Viola Weich, Gerlinde Teuber, et al.
Clinics and Research in Hepatology and Gastroenterology|September 16, 2023
Granulocyte colony stimulating factor in decompensated cirrhosis, acute alcoholic hepatitis, and acute-on-chronic liver failure: A comprehensive meta-analysis of randomized controlled trialsVincent Di Martino, Josselin Questiaux, Tristan Lemagoarou, et al.
Scientific Reports|December 28, 2023
Changes of the bacterial composition in duodenal fluid from patients with liver cirrhosis and molecular bacterascitesJim Höppner, Sandra Krohn, Ellen H A van den Munckhof, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2021
A genetic variant in toll-like receptor 5 is linked to chemokine levels and hepatocellular carcinoma in steatohepatitisHans Dieter Nischalke, Janett Fischer, Alexandra Klüners, et al.
Blood|October 24, 2002
Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemiaAndreas Burchert, Stefan Wölfl, Manuel Schmidt, et al.
European Journal of Gastroenterology & Hepatology|October 8, 2019
Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register)Johannes Wiegand, Peter Buggisch, Stefan Mauss, et al.
Pageof 64

Showing results (401-410 of 632) with videos related to

Sort By:
Pageof 64
Journal of Clinical Medicine|February 15, 2022
Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing CholangitisAnne-Christin Beatrice Wilde, Lena Maria Greverath, Lara Marleen Steinhagen, et al.
European Journal of Gastroenterology & Hepatology|October 2, 2009
Influence of alpha-1 antitrypsin heterozygosity on treatment efficacy of HCV combination therapyKarin F Kok, Hanneke van Soest, Antonius E van Herwaarden, et al.
Journal of Hepatology|November 1, 2011
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort studyJorg Petersen, Vlad Ratziu, Maria Buti, et al.
Gastroenterology|July 6, 2010
Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infectionThomas Berg, Patrick Marcellin, Fabien Zoulim, et al.
Hepatology (Baltimore, Md.)|July 4, 2009
Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patientsThomas Berg, Viola Weich, Gerlinde Teuber, et al.
Clinics and Research in Hepatology and Gastroenterology|September 16, 2023
Granulocyte colony stimulating factor in decompensated cirrhosis, acute alcoholic hepatitis, and acute-on-chronic liver failure: A comprehensive meta-analysis of randomized controlled trialsVincent Di Martino, Josselin Questiaux, Tristan Lemagoarou, et al.
Scientific Reports|December 28, 2023
Changes of the bacterial composition in duodenal fluid from patients with liver cirrhosis and molecular bacterascitesJim Höppner, Sandra Krohn, Ellen H A van den Munckhof, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2021
A genetic variant in toll-like receptor 5 is linked to chemokine levels and hepatocellular carcinoma in steatohepatitisHans Dieter Nischalke, Janett Fischer, Alexandra Klüners, et al.
Blood|October 24, 2002
Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemiaAndreas Burchert, Stefan Wölfl, Manuel Schmidt, et al.
European Journal of Gastroenterology & Hepatology|October 8, 2019
Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register)Johannes Wiegand, Peter Buggisch, Stefan Mauss, et al.
Pageof 64